BioMedWire Stocks Archives - Page 8 of 66

FridayDec 13, 2024 10:00 am

New Technology Programs Immune Cells to Combat Brain Cancer, MS

Glioblastoma multiforme is an aggressive type of cancer that usually affects an individual’s spinal cord or brain. Brain cancers, which are among the most difficult cancers to treat, are the primary cause of cancer deaths in kids. The main treatments of this cancer include chemotherapy and surgery, with medications being a less prescribed option as they can’t always access the brain. Now researchers at the University of California-San Francisco have discovered a new way to alter immune cell behavior to attack glioblastoma. For their study, they came up with a molecular GPS that could lead immune cells to the brain…

ThursdayDec 12, 2024 10:00 am

Why Retirees Should Think Carefully Before Enrolling for Medical Advantage

Retirees have benefited a lot from the Medicare program since its inception in 1965. With the 2025 open enrollment period for the program approaching, some may be thinking about switching to a Medicare Advantage plan. While these plans may appeal to the masses with their low premiums, they aren’t the best choice for every individual. Below, we discuss things retirees need to consider before moving to Medicare Advantage, as well as why they may prefer to remain covered under Original Medicare. So, what should retirees know about Medicare Advantage? For starters, these plans have limited provider networks as they operate…

TuesdayDec 10, 2024 10:00 am

New Staging System Could Forecast How Quickly Parkinson’s Might Progress After Diagnosis

In the early stages of Parkinson’s disease, alpha-synuclein accumulates in the brain, damaging nerve cells that produce dopamine. Dopamine is a hormone that regulates movement. Its absence in the brain can cause movement problems, among other symptoms. Investigators believe that alpha-synuclein accumulates in the brain for years before patients begin presenting with symptoms. Alpha-synuclein is a protein that forms Lewy bodies, which scientists believe may be the cause of Parkinson’s. Following research from last year that found that this protein could be detected in living patients via cerebrospinal fluid, investigators decided to use biological indicators to help develop a more…

ThursdayDec 05, 2024 10:00 am

New Computational Model Explains Behavioral and Neural Differences in ASD

Autism spectrum disorder is a developmental and neurological disorder that affects how an individual communicates with others, interacts with them and behaves, as well as learns. Researchers have developed a new computational model to explain the behavioral and neural differences in autism spectrum disorder. The new model provides new insights into information processing in the brains of persons living with autism, which may in turn broaden the horizons of future studies. The model was designed by Oded Wertheimer and Dr. Yuval Hart from the Department of Psychology at The Hebrew University of Jerusalem. It focuses on the dynamic range, which…

TuesdayDec 03, 2024 10:00 am

e-Commerce Sees New Record as Thanksgiving Shoppers Go All Out on Spending

2024 saw Thanksgiving sales increase, with mobile and e-commerce purchases hitting new highs. An analysis conducted by Adobe Analytics determined that by the end of November 28th, online consumers had spent $6.1 billion during Thanksgiving. This figure represents an 8.8% increase from 2023’s Thanksgiving sales. Adobe Digital Insights’ lead analyst Vivek Pandya stated that Cyber Week had started on a strong high, with huge discounts driving impulse shopping in categories like apparel and electronics. Cyber Week refers to the 5-day period which includes Thanksgiving, Black Friday and Cyber Monday. This year, Cyber Monday was on December 2nd. Salesforce, an e-commerce…

MondayDec 02, 2024 10:00 am

AI Model Promises New Way to Detect Brain Malignancies

Central nervous system and brain cancers accounted for 248,500 deaths globally in 2022. In America, roughly 90,000 brain tumors are diagnosed annually, with data from the American Cancer Society showing that over 25,000 of these tumors are cancerous. It is projected that there’ll be an estimated 25,400 new cases of central nervous system and brain cancers in 2024. Estimates also show that roughly one million individuals in the U.S. live with a primary brain tumor, with about 28% of all brain tumors being malignant. Glioblastoma, a fatal form of brain cancer, accounts for 50% of all malignant brain tumors in…

TuesdayNov 26, 2024 10:00 am

MS Drug Could Counter Poor Working Memory

A new study has determined that a medication normally prescribed for multiple sclerosis can help persons with poor working memory. Working memory is an important component of cognitive function. Sadly, it is often impaired in patients with conditions like schizophrenia. The study was led by University of Basel’s Professors Dominique de Quervain and Andreas Papassotiropoulos. For their randomized and double-blind study, the researchers tested the efficacy of fampridine on the working memory of forty-three healthy adults. Fampridine, the medication in question, is normally used to enhance walking ability for patients with multiple sclerosis. Patients with this chronic illness often experience…

FridayNov 22, 2024 10:00 am

Could a Medicare Special Needs Plan Be Right for You?

A Special Needs Plan (SNP) customizes medical benefits for individuals who have chronic illnesses, are on Medicaid, or live in specific institutions. SNPs are offered under Medicare Advantage, with figures showing that enrollees under this plan may hit 28% by next year. What should you know about SNPs? They cover hospital care (Part A), physician visits and some other charges (Part B) and prescription drugs (Part D). There are three kinds of SNPs; Chronic condition SNPs These plans cover patients with disabling or severe chronic diseases like diabetes, stroke, chronic heart failure, and cancer. Dual-eligible SNPs This covers individuals eligible…

ThursdayNov 21, 2024 10:00 am

Research Suggests Cancer Survivors are Less Prone to Alzheimer’s Development

Alzheimer’s and cancer are common diagnoses, especially among older individuals. Prior research has observed an inverse association between both conditions, with a separate study also finding that survivors of cancer have a lower risk of developing Alzheimer’s in comparison to individuals without a history of cancer. Now new research has uncovered evidence of a lower prevalence of dementia following a patient’s cancer diagnosis. The research was carried out by scientists at Imperial College, who focused on health data of over three million individuals aged 60 and above. The scientists performed genetic analyzes on hundreds of genes, finding a genetic profile…

TuesdayNov 19, 2024 10:00 am

New Drug Approach Could Roll Back Pancreatic Cancer Immunotherapy Resistance

New research by scientists from the Oregon Health & Science University and Johns Hopkins Kimmel Cancer Center has found a new approach that can make tumors resistant to immunotherapy vulnerable to the treatment. For their study, the researchers evaluated the effectiveness and safety of the combination of 2 medications; entinostat, an epigenetic drug; and nivolumab, an immunotherapy medication. The drugs were administered to a group of twenty-seven patients with advanced pancreatic ductal adenocarcinoma. The patients had in the past undergone chemotherapy. The immune activity in the microenvironment of patients with this common type of pancreatic cancer is suppressed, which allows…